POS0855 PATIENT PREFERENCES, TRADE-OFFS AND ACCEPTABLE RISKS IN THE TREATMENT OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A STEP TOWARDS SHARED DECISION-MAKING
Cosimo Bruni(University of Florence), Oliver Distler(University Hospital of Zurich), É. Hachulla(Centre Hospitalier Universitaire de Lille), Sebastian Heidenreich(Physikalisch-Technische Bundesanstalt), Jörg H. W. Distler(Düsseldorf University Hospital), Marie‐Elise Truchetet(Centre National de la Recherche Scientifique), Nicolas Hunzelmann(University Hospital Cologne), Yannick Allanore(Inserm), Alexander Carreño Dueñas, Vivien Hsu(Rutgers, The State University of New Jersey), Dinesh Khanna(University of Michigan), Nils Schoof(Bayer (Germany)), Emmanuel Chatelus(Laboratoire National de Référence), M. Alves(Boehringer Ingelheim (Germany)), Armando Gabrielli(Marche Polytechnic University), Anna‐Maria Hoffmann‐Vold(University of Oslo), Lesley Ann Saketkoo(Tulane University), Ulrich A. Walker(University Hospital of Basel)
Cited by 1
Related Papers
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Meso-scale turbulence in living fluids
|Proceedings of the National Academy of Sciences|2012|987
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
|New England Journal of Medicine|2009|857
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
|Nature Communications|2012|824